Report cover image

In Vitro Diagnostic (IVD) Trends and Market Update, December 2025

Publisher Kalorama Information
Published Dec 05, 2025
Length 52 Pages
SKU # KLI20630970

Description

Kalorama Information’s In Vitro Diagnostic (IVD) Trends and Market Update, 2025 delivers critical insights into the evolving IVD market amid global economic uncertainties. Published twice annually—in April and in December following the release of Kalorama’s flagship study, The Worldwide Market for In Vitro Diagnostics (IVD), 18th Edition—this report serves as both a standalone resource and a strategic companion for decision-makers in the diagnostics industry.

The 2025 IVD market continues its growth trajectory, fueled by technological breakthroughs and rising healthcare demands. Innovations in next-generation sequencing (NGS), microfluidics, and precision medicine are transforming diagnostics, enabling highly accurate, sensitive, and personalized testing for complex conditions such as cancer and genetic disorders. The surge in companion diagnostics and multiplex testing underscores a shift toward patient-centric care and deeper disease insights.

Key growth segments attracting industry attention include Point-of-Care testing, cancer diagnostics, companion diagnostics technologies, immunochemistry, and mass spectrometry. Nucleic acid assays, gene testing, and HPV molecular diagnostics are poised for significant expansion, shaping the future of IVD.

This report provides actionable intelligence on:
  • Market drivers and major industry trends
  • New product developments shaping innovation
  • Competitive landscape and key player strategies
  • Emerging opportunities and high-growth segments
With expert analysis and up-to-date data, Kalorama equips executives, industry leaders, and investors with the tools to navigate regulatory challenges, capitalize on technological advancements, and identify profitable opportunities in the dynamic IVD sector.

Table of Contents

52 Pages
CHAPTER ONE: WORLDWIDE IVD MARKET – DECEMBER 2025 UPDATE
ABOUT KALORAMA INFORMATION
IVD MARKET DEMAND AND GROWTH
Figure 1-1: Q1-Q3 IVD Segment Performance Commentary, 2025 [Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology (Molecular), Point-of-Care (POC)]
Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2025 ($ million) [Blood Bank Molecular - NAT Screens; Blood Grouping/Typing; Circulating Tumor Cells; Clinical Chemistry; Coagulation (PT/INR); Coagulation, Molecular; D-dimer; Diabetes HbA1c, lab; Drugs of Abuse; Hematology - Core Lab; Histology/Cytology; HPV, Molecular; Immuno - Blood Bank Screening; Immuno-Infectious Disease; Immunoassays - Non-isotopic; Mass Spectrometry; Microbiology (ID/AST); Microbiology (Molecular); Microbiology - Mass Spectrometry; NAAT - Oncology; Nucleic Acid Assays - Genetic/Inherited; Other Immunos; POC, OTC Diabetes; POC, OTC Other; POC, Professional/Hospital]
Figure 1-2: IVD Segment Performance, Q1 2025–Q4 2025 estimated ($ million) [Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, Point-of-Care (POC), Other]
Figure 1-3: IVD Segment Performance, Total Market Value, 2025 estimated ($ million) [Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, Point-of-Care (POC), Other]
COVID-19 Diagnostic Markets
Table 1-2: COVID-19 Product Sales, 2025 ($ million) [Immunoassay (Antigen, Serology), Molecular, Rapid]
EFFECT OF COVID-19 ON MARKET SEGMENTS
Table 1-3: IVD Market excluding and including COVID-19, 2025 ($ million)
Figure 1-4: IVD Market Distribution, by Segment, 2025 (%) [COVID-19 Assays and Instruments, IVD Market excluding COVID-19 Assays and Instruments]
Figure 1-5: IVD Market by COVID-19 and non-COVID markets, Quarterly Performance, 2025 estimated ($ million)
Table 1-4: Global In Vitro Diagnostic Market – YoY Growth, 2024-2025 (%) [Blood Bank Molecular - NAT Screens, Blood Grouping/Typing, Circulating Tumor Cells, Clinical Chemistry, Coagulation (PT/INR), Coagulation, Molecular, D-dimer, Diabetes HbA1c, Lab, Drugs of Abuse, Hematology - Core Lab, Histology/Cytology, HPV, Molecular, Immuno - Blood Bank Screening, Immuno - Infectious Disease, Immunoassays- non-isotopic, Microbiology (ID/AST), Microbiology (Molecular), Microbiology - Mass Spectrometry, NAAT - Oncology, Nucleic Acid Assays - Genetic/Inherited, Other Immunos, POC, OTC Diabetes, POC, OTC Other, POC, Professional/Hospital]
Figure 1-6: Global In Vitro Diagnostic Market – YoY Growth 2024-2025 (%) [Blood Bank Molecular - NAT Screens, Blood Grouping/Typing, Circulating Tumor Cells, Clinical Chemistry, Coagulation (PT/INR), Coagulation, Molecular, D-dimer, Diabetes HbA1c, Lab, Drugs of Abuse, Hematology - Core Lab, Histology/Cytology, HPV, Molecular, Immuno - Blood Bank Screening, Immuno - Infectious Disease, Immunoassays- non-isotopic, Microbiology (ID/AST), Microbiology (Molecular), Microbiology - Mass Spectrometry, NAAT - Oncology, Nucleic Acid Assays - Genetic/Inherited, Other Immunos, POC, OTC Diabetes, POC, OTC Other, POC, Professional/Hospital
CHAPTER TWO: PRODUCT TRENDS AND NEW DEVELOPMENTS
SELECTED NEW – Q3 2025 - CORE IVD PRODUCT LAUNCHES, DEVELOPMENTS AND TRENDS
Immunoassay
Mass Spectrometry
Molecular
Personalized Medicine
POC
Coagulation
Flow Cytometry
Sequencing
SELECTED COVID-19 DEVELOPMENTS – Q3 2025
Antigen/Antibody
Molecular
CHAPTER THREE: TOP IVD MARKET PARTICIPANT RESULTS
SELECTED COMPETITIVE LEADER UPDATES
Figure 3-1: IVD Segment Growth by Leading Competitors, Change in Sales 2024-2025 (%)
Figure 3-2: Changes in Market Distribution for IVD Sales, 2022-2025 estimated (%)
Figure 3-3: Comparison of Total Diagnostic Sales for Abbott vs Roche, 2023-2025 estimated ($ million)
Q3 2025 M&A ACTIVITY
Table 3-1: Q3 2025 Merger and Acquisition Activity
ABBOTT LABORATORIES
Table 3-2: Abbott Corporate Summary
BECTON DICKINSON AND CO
Table 3-3: Becton Dickinson Corporate Summary
BIOMÉRIEUX SA
Table 3-4: bioMérieux Corporate Summary
DANAHER CORPORATION
Table 3-5: Danaher Corporation Summary
DEXCOM, INC
Table 3-6: Dexcom Corporate Summary
EXACT SCIENCES
Table 3-7: Exact Sciences Corporate Summary
ROCHE DIAGNOSTIC
Table 3-8: Roche Diagnostic Corporate Summary
SIEMENS HEALTHINEERS
Table 3-9: Siemens Healthineers Corporate Summary
SYSMEX CORPORATION
Table 3-10: Sysmex Corporate Summary
THERMO FISHER SCIENTIFIC
Table 3-11: Thermo Fisher Scientific Corporate Summary
CHAPTER FOUR: NEW OPPORTUNITIES
PERSONALIZED MEDICINE
GENETIC TESTING IN DISEASE
MICROBIOME
IVD DIGITAL DIAGNOSTICS
TARIFFS

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us